Treatment of advanced carcinoma of the prostate by LHRH-agonists.
D002064:Buserelin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017373:Cyproterone Acetate; D017273:Goserelin; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood
D017273:Goserelin; D013739:Testosterone; D017373:Cyproterone Acetate; D003534:Cyproterone; D002064:Buserelin